Skip to main content
The Egyptian Journal of Internal Medicine
Fig. 1 | The Egyptian Journal of Internal Medicine

Fig. 1

From: A novel biomarker of chronic allograft dysfunction in renal transplant recipients (serum calreticulin and CD47)

Fig. 1

Receiver operating characteristic curve (ROC) shows that the sensitivity and specificity of the high-sensitivity C-reactive protein (hsCRP) level in discriminating renal transplant recipients with stable allograft function from renal transplant recipients with chronic allograft dysfunction were 73.3% and 60%, respectively, at a cut-off level of 6 mg/l (area under the curve = 0.798)

Back to article page